President-elect Donald Trump drew another expression of support on Tuesday, as a billionaire businessman from the United Arab ...

With yields on the 30-year Treasury bond at their highest level in a year, the so-called Magnificent Seven group’s ...

NatWest Group PLC NWG shares shed 3.54% to £3.95 Tuesday, on what proved to be an all-around rough trading session for the ...

Shares of National Grid PLC NG inched down 0.25% to £9.40 Tuesday, on what proved to be an all-around rough trading session ...

Rio Tinto PLC RIO shares slid 1.02% to £46.66 Tuesday, on what proved to be an all-around poor trading session for the stock ...

It had seemed like nothing could stop the U.S. dollar from marching higher. Then a headline about President-elect Donald ...

UBS analyst Erika Najarian has singled out Bank of America Corp.’s stock as an overlooked bargain that could rise about 20% ...

The holiday shopping season gave a boost to service-oriented companies in December, but top executives were wary of potential ...

The U.S. stock market remained the envy of the world in 2024, extending its outperformance against international peers and ...

The U.S. economy and markets outcompeted other nations throughout 2024. That could continue in 2025 as well, says Wells Fargo ...

U.S. crude-oil inventories likely fell for a seventh consecutive week, while gasoline and diesel stocks are seen rising from the week before, according to a survey by The Wall Street Journal.

MAIA Biotechnology's shares rose 19% to $2.46 after the company said it entered into a clinical supply agreement with BeiGene to evaluate THIO, MAIA's telomere-targeting anticancer agent.